Sue Sturrock
About
In The Last Decade
Sue Sturrock
7 papers receiving 460 citations
Peers
Comparison fields: 5 of 48
- Immunology 308
- Oncology 279
- Molecular Biology 161
- Pulmonary and Respiratory Medicine 89
- Radiology, Nuclear Medicine and Imaging 49
Countries citing papers authored by Sue Sturrock
This map shows the geographic impact of Sue Sturrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Sturrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Sturrock more than expected).
Fields of papers citing papers by Sue Sturrock
This network shows the impact of papers produced by Sue Sturrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Sturrock. The network helps show where Sue Sturrock may publish in the future.
Co-authorship network of co-authors of Sue Sturrock
This figure shows the co-authorship network connecting the top 25 collaborators of Sue Sturrock. A scholar is included among the top collaborators of Sue Sturrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Sturrock. Sue Sturrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 125 | |
| 2 | 186 | |
| 3 | Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination. | 33 |
| 4 | 51 | |
| 5 | Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. | 64 |
| 6 | 6 | |
| 7 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.